Strides Pharma Inc.

FDA Regulatory Profile

Strides Pharma Inc. has 14 FDA recalls, 11 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest recall
D-0079-2027 · Class II · Oct 7, 2026
Latest inspection
Feb 16, 2024 · NAI

Reviewing Strides Pharma Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Strides Pharma Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls14Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections11Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Strides Pharma Science Limited
Same company group
10131Feb 17, 2020 (D-1029-2020)
Strides Pharma Private Limited
Same company group
0070—

Recent Recalls

NumberClassProductDate
D-0079-2027Class IICinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd…Oct 7, 2026
D-0390-2026Class IIChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured…Mar 2, 2026
D-0546-2025Class IICinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd…Jul 9, 2025
D-0294-2025Class IITestosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides…Mar 5, 2025
D-0293-2025Class IITestosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides…Mar 5, 2025
D-0260-2024Class IIMethoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science…Dec 29, 2023
D-0895-2023Class IILosartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured…Jun 26, 2023
D-1330-2022Class IIPrednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science…Jul 19, 2022
D-0973-2022Class IILosartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private…May 18, 2022
D-0974-2022Class IILosartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private…May 18, 2022
D-0972-2022Class IILosartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private…May 18, 2022
D-0006-2022Class IIPotassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured…Sep 27, 2021
D-0180-2021Class IIINDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma…Dec 22, 2020
D-0858-2017Class IIIBenzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited…May 9, 2017

Recent FDA Inspections

DateSiteProductClassificationFEI
Feb 16, 2024East Brunswick, NJDrugsNo Action Indicated (NAI)3011707936
Feb 8, 2022Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223
Aug 23, 2019Chestnut Ridge, NYDrugsNo Action Indicated (NAI)2434223
Jun 5, 2019Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223
Apr 18, 2018East Brunswick, NJDrugsVoluntary Action Indicated (VAI)3011707936
Mar 16, 2017Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223
Jun 4, 2015Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223
Feb 19, 2013Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223
Apr 4, 2012Chestnut Ridge, NYDrugsNo Action Indicated (NAI)2434223
May 4, 2011Chestnut Ridge, NYDrugsNo Action Indicated (NAI)2434223
Aug 7, 2009Chestnut Ridge, NYDrugsVoluntary Action Indicated (VAI)2434223

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3011707936East Brunswick, NJ2Feb 16, 2024
FEI 2434223Chestnut Ridge, NY9Feb 8, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.